ID: ALA3675793

Max Phase: Preclinical

Molecular Formula: C14H13N3O2

Molecular Weight: 255.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccnc1-c1nc2ccc(CO)cc2[nH]1

Standard InChI:  InChI=1S/C14H13N3O2/c1-19-12-3-2-6-15-13(12)14-16-10-5-4-9(8-18)7-11(10)17-14/h2-7,18H,8H2,1H3,(H,16,17)

Standard InChI Key:  LPTNEAOJZHHLRG-UHFFFAOYSA-N

Associated Targets(Human)

Core-binding factor subunit beta 36 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 255.28Molecular Weight (Monoisotopic): 255.1008AlogP: 2.13#Rotatable Bonds: 3
Polar Surface Area: 71.03Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.03CX Basic pKa: 2.00CX LogP: 1.53CX LogD: 1.53
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.75Np Likeness Score: -0.52

References

1.  (2014)  Inhibitors of inv(16) leukemia, 

Source

Source(1):